ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Milano, Lombardia

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Type 2 Diabetes Mellitus
Diabetes Mellitus
Obesity
Type 1 Diabetes Mellitus
Overweight
Diabetic Foot
Foot Ulcer

Diabetes trials near Milano, Lombardia, ITA:

A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 Diabetes (SURPASS-EARLY)

This study aims to investigate the efficacy and safety of tirzepatide in participants with type 2 diabetes (T2D) compared to other existing ...

Active, not recruiting
Type 2 Diabetes
Drug: Antihyperglycemic medication
Drug: Tirzepatide

Phase 4

Lilly
Lilly

Milan, Milano, Italy and 89 other locations

also to as NMX8 system), in comparison with other commercially available AID systems (Automated insulin delivery) in adult patients with Type 1 diabetes...

Begins enrollment in 3 months
Type 1 Diabetes (T1D)
Device: AID Therapy
Device: NMX8 System - Control Arm
Medtronic MiniMed, Inc.

Milan, Italy and 20 other locations

To compare in diabetic patients eligible for percutaneous coronary intervention (PCI) with minimal exclusion criteria, the efficacy and safe...

Active, not recruiting
Diabetes
Coronary Artery Disease
Device: XIENCE Everolimus Eluting Coronary Stent System (XIENCE family)
Device: Abluminus DES+ Sirolimus Eluting Stent System (SES)
Concept Medical
Concept Medical

Milano, Italy and 89 other locations

New

in pediatric participants aged 10 to less than 18 years with type 2 diabetes. The study will also check how safe these medicines are and how...

Begins enrollment in 2 months
Diabetes Mellitus, Type 2
Drug: Orforglipron
Drug: Dulaglutide

Phase 3

Lilly
Lilly

Milan, Italy and 70 other locations

The purpose of the study is to evaluate the safety, tolerability, and efficacy of VX-264 in participants with type 1 diabetes (T1D)....

Active, not recruiting
Type 1 Diabetes
Drug: VX-264

Phase 1, Phase 2

Vertex Pharmaceuticals
Vertex Pharmaceuticals

Milan, Italy and 15 other locations

The primary objective of this study is to demonstrate that maridebart cafraglutide is superior to placebo for percent change in body weight.

Active, not recruiting
Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight
Drug: Maridebart cafraglutide
Drug: Placebo

Phase 3

Amgen
Amgen

Milan, Italy and 187 other locations

parallel-arm study to evaluate the efficacy, safety and tolerability of SAB 142 in patients with Stage 3 New Onset of Type 1 Diabetes (NOT1D...

Enrolling
Type 1 Diabetes
Drug: Low Dose SAB-142
Other: Placebo

Phase 2

Sab Biotherapeutics

Milan, Italy and 70 other locations

This study will evaluate the safety, tolerability and efficacy of VX-880 infusion in participants with Type 1 diabetes (T1D) and impaired aw...

Enrolling
Diabetes Mellitus, Type 1
Impaired Hypoglycemic Awareness
Biological: VX-880

Phase 3

Vertex Pharmaceuticals
Vertex Pharmaceuticals

Milan, Italy and 28 other locations

The purpose of this study is to find out if baricitinib can delay the onset of clinical type 1 diabetes (T1D) in people who are at high risk...

Enrolling
Diabetes Mellitus, Type 1
Drug: Baricitinib
Drug: Placebo

Phase 3

Lilly
Lilly

Milan, Italy and 106 other locations

The purpose of this study is to evaluate the efficacy, safety, and tolerability of elecoglipron compared with oral semaglutide in adults with T2DM an...

Begins enrollment this month
Type 2 Diabetes Mellitus
Drug: Elecoglipron
Drug: Semaglutide

Phase 3

AstraZeneca
AstraZeneca

Milan, Italy and 157 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems